SlideShare a Scribd company logo
1 of 1
Molecular and Cellular Biochemistry
April 1993, Volume 121, Issue 1, pp 1–4
Parathyroid hormone in urinary stone
patients
 Authors
 Authors and affiliations
 Aziza Khanam
 M. Ataur Rahman
Article
Received:
18 March 1992
Accepted:
08 September 1992
DOI: 10.1007/BF00928693
Cite this article as:
Khanam, A. & Rahman, M.A. Mol Cell Biochem (1993) 121: 1.
doi:10.1007/BF00928693
 1Citations
 15Downloads
Abstract
To evaluate the role of parathyroids in calculus disease, the parathyroid hormone levels were
determined in 22 control subjects and 42 stone (14 with bladder stone and 28 with kidney stone)
patients. Serum calcium, inorganic phosphate, alkaline phosphatase and parathyroid hormone
and urinary excretion of calcium and inorganic phosphate were determined. It was found that
normocalcemic and normocalciuric stone patients had slightly higher levelsss of parathyroid
hormone (irrespective of the site of the stone) and the difference was not statistically significant
as compared with control subjects although some of the patients with calculus disease were
hyperparathyroid. Serum alkaline phosphatase was increased while there was an increase in
urinary calcium excretion in kidney stone patients and oxalate in all patients as compared with
control subjects. The increase in inorganic phosphate was, however, not different from the
control subjects. The subclinical hyperparathyroidism and stone formation in these patients are
not correlated.

More Related Content

More from Aziza Qadeer

Evaluation of toxicities induced by chemotherapy in breast cancer patients
Evaluation of toxicities induced by chemotherapy in breast cancer patientsEvaluation of toxicities induced by chemotherapy in breast cancer patients
Evaluation of toxicities induced by chemotherapy in breast cancer patientsAziza Qadeer
 
article_wjpps_1407742975 (1)
article_wjpps_1407742975 (1)article_wjpps_1407742975 (1)
article_wjpps_1407742975 (1)Aziza Qadeer
 
ANTIOXIDANT VITAMINS IN DIABETES
ANTIOXIDANT VITAMINS IN DIABETES ANTIOXIDANT VITAMINS IN DIABETES
ANTIOXIDANT VITAMINS IN DIABETES Aziza Qadeer
 
ALPHA -TOCOPHEROL IN CANCER
ALPHA -TOCOPHEROL IN CANCERALPHA -TOCOPHEROL IN CANCER
ALPHA -TOCOPHEROL IN CANCERAziza Qadeer
 
30-RELETIONSHIP OF NITRIC (DR SADIA ISHAQUE) 607-611
30-RELETIONSHIP OF NITRIC (DR SADIA ISHAQUE) 607-61130-RELETIONSHIP OF NITRIC (DR SADIA ISHAQUE) 607-611
30-RELETIONSHIP OF NITRIC (DR SADIA ISHAQUE) 607-611Aziza Qadeer
 
hepatotoxicity all (1)
hepatotoxicity all (1)hepatotoxicity all (1)
hepatotoxicity all (1)Aziza Qadeer
 

More from Aziza Qadeer (9)

Paper-19
Paper-19Paper-19
Paper-19
 
HPshjg (2)
HPshjg (2)HPshjg (2)
HPshjg (2)
 
Fg5V2T
Fg5V2TFg5V2T
Fg5V2T
 
Evaluation of toxicities induced by chemotherapy in breast cancer patients
Evaluation of toxicities induced by chemotherapy in breast cancer patientsEvaluation of toxicities induced by chemotherapy in breast cancer patients
Evaluation of toxicities induced by chemotherapy in breast cancer patients
 
article_wjpps_1407742975 (1)
article_wjpps_1407742975 (1)article_wjpps_1407742975 (1)
article_wjpps_1407742975 (1)
 
ANTIOXIDANT VITAMINS IN DIABETES
ANTIOXIDANT VITAMINS IN DIABETES ANTIOXIDANT VITAMINS IN DIABETES
ANTIOXIDANT VITAMINS IN DIABETES
 
ALPHA -TOCOPHEROL IN CANCER
ALPHA -TOCOPHEROL IN CANCERALPHA -TOCOPHEROL IN CANCER
ALPHA -TOCOPHEROL IN CANCER
 
30-RELETIONSHIP OF NITRIC (DR SADIA ISHAQUE) 607-611
30-RELETIONSHIP OF NITRIC (DR SADIA ISHAQUE) 607-61130-RELETIONSHIP OF NITRIC (DR SADIA ISHAQUE) 607-611
30-RELETIONSHIP OF NITRIC (DR SADIA ISHAQUE) 607-611
 
hepatotoxicity all (1)
hepatotoxicity all (1)hepatotoxicity all (1)
hepatotoxicity all (1)
 

Molecular and Cellular Biochemistry

  • 1. Molecular and Cellular Biochemistry April 1993, Volume 121, Issue 1, pp 1–4 Parathyroid hormone in urinary stone patients  Authors  Authors and affiliations  Aziza Khanam  M. Ataur Rahman Article Received: 18 March 1992 Accepted: 08 September 1992 DOI: 10.1007/BF00928693 Cite this article as: Khanam, A. & Rahman, M.A. Mol Cell Biochem (1993) 121: 1. doi:10.1007/BF00928693  1Citations  15Downloads Abstract To evaluate the role of parathyroids in calculus disease, the parathyroid hormone levels were determined in 22 control subjects and 42 stone (14 with bladder stone and 28 with kidney stone) patients. Serum calcium, inorganic phosphate, alkaline phosphatase and parathyroid hormone and urinary excretion of calcium and inorganic phosphate were determined. It was found that normocalcemic and normocalciuric stone patients had slightly higher levelsss of parathyroid hormone (irrespective of the site of the stone) and the difference was not statistically significant as compared with control subjects although some of the patients with calculus disease were hyperparathyroid. Serum alkaline phosphatase was increased while there was an increase in urinary calcium excretion in kidney stone patients and oxalate in all patients as compared with control subjects. The increase in inorganic phosphate was, however, not different from the control subjects. The subclinical hyperparathyroidism and stone formation in these patients are not correlated.